Real World Data (RWD)

In the healthcare context, the most promising big data are known as Real World Data (RWD). RWD allow you to photograph the different dimensions of a person’s mental and physical well-being and the general state of health, to evaluate the effect of the introduction of new medical technologies or health tools, such as drugs, medical devices or diagnostic-therapeutic care pathways. RWD can be used in the healthcare and pharmaceutical fields to affirm, demonstrate and / or confirm the value of a treatment throughout its life cycle, supporting health care based on Real World Evidence (RWE).

Real World Data (RWD) are health data not collected from conventional randomized clinical trials (RCTs), which allow you to measure what happens in real clinical practice, namely:

  • cross-sectional and longitudinal administrative databases
  • disease registries and drug registries
  • population surveys for the collection of epidemiological information and health surveys
  • observational cohort studies
  • pragmatic studies
  • pragmatic studies, that is, randomized clinical trials that, with the aim of simulating real-life conditions, use less rigid inclusion / exclusion criteria than pre-registration conventional RCTs, and consider outcomes whose clinical impact is as close as possible to that observed in clinical practice.
  • electronic medical records for the collection of patient health data


  • Definition and implementation of Real World Data analysis and Real World Evidence Reports;
  • Support with Real World Data (RWD) for a national and regional planning and programming of pharmaceutical and health expenditure based on Real World Evidence (RWE);
  • Governance systems and organizational tools for monitoring and evaluating the appropriateness of pharmaceutical and healthcare expenditure;
  • Definition of specific indicators and permanent observers of populations and assessment of the use of medicines and medical devices in terms of Outcome Research;
  • Scientific dissemination and information and education at different levels (international, national and local) through reviews and scientific publications;
  • Training and updating through Masters and training courses and scientific conferences for health professionals and public / private decision makers operating in the life sciences market.